Pharmaceutical Technology11 小时
Cabometyx by Exelixis for Salivary Gland Cancer: Likelihood of Approval
Cabometyx is under clinical development by Exelixis and currently in Phase II for Salivary Gland Cancer. According to GlobalData, Phase II drugs for Salivary Gland Cancer have a 14% phase transition ...
Pharmaceutical Technology11 小时
Cemiplimab by Regeneron Pharmaceuticals for Colorectal Cancer: Likelihood of Approval
Cemiplimab is under clinical development by Regeneron Pharmaceuticals and currently in Phase II for Colorectal Cancer.
pancan17 小时
ABOUT Pancreatic Cancer
More than 66,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.